TY  - GEN
AU  - Suez,Daniel
AU  - Kriván,Gergely
AU  - Jolles,Stephen
AU  - Stein,Mark
AU  - Gupta,Sudhir
AU  - Paris,Kenneth
AU  - van Hagen,P Martin
AU  - Brodszki,Nicholas
AU  - Engl,Werner
AU  - Leibl,Heinz
AU  - McCoy,Barbara
AU  - Yel,Leman
TI  - Safety and tolerability of subcutaneous immunoglobulin 20% in primary immunodeficiency diseases from two continents
SN  - 1750-7448
PY  - 2020///0525
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Child
KW  - Child, Preschool
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - epidemiology
KW  - Europe
KW  - Female
KW  - Humans
KW  - Immunoglobulin G
KW  - therapeutic use
KW  - Injections, Subcutaneous
KW  - Male
KW  - Middle Aged
KW  - North America
KW  - Primary Immunodeficiency Diseases
KW  - drug therapy
KW  - Prospective Studies
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.2217/imt-2019-0057
ER  -